Documentation Centre

Flash required
September 05, 2012
Are pharmacological approaches to increasing HDL cholesterol clinically relevant in reducing the risk of atherogenic dyslipidemia and abdominal obesity?
By Ronald Krauss, MD, Children's Hospital Oakland Research Institute, Atherosclerosis Research, Oakland, CA, USA [0:43 min.] [3MB]

  • See all Expert Opinions of Ronald Krauss, MD, Children's Hospital Oakland Research Institute, Atherosclerosis Research, Oakland, CA, USA

Download Video


Key Words
Abdominal Obesity/Body Fat Distribution, Lipids/Lipoproteins, Documentation Centre